Epilepsy Foundation – News Release – New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
Epilepsy Foundation – Position Statement on the substitution of antiepileptic drugs by pharmacists and public and private payers, without the knowledge and prior approval of the patient and treating physician.
FDA - Generic Drugs: What You Need to Know – 2002 Q&A about generic drugs – states that they’re safe to use because the FDA requires generics to be safe and effective, and that “people can use them with total confidence.”
FDA/Center for Drug Evaluation and Research – FDA Ensures Equivalence of Generic Drugs – 2003 This article explains steps taken to review a drug, the FDA’s requirements for brand name and generic drugs, myths and facts about generic drugs, and bioequivalence.
FDA - FDA Generic Drugs Final Rule and Initiative – 2003 Features links to the FDA’s fact sheet, white paper, and Q&A on their Final Rule about the regulations of generic drugs. This article also emphasizes the importance of saving money with generic drugs by streamlining and perfecting the process of generic drug review and production.
AAN - Policy StatementThe American Academy of Neurology (AAN), representing over 19,000 neurologists and neuroscience professionals, has taken an active interest in the clinical, ethical and policy considerations concerning the coverage of anticonvulsant drugs for people with epilepsy.
AES - Policy Statement Position statement regarding the substitution of different formulations of antiepileptic drugs from the American Epilepsy Society (AES)
Epilepsy Foundation – Alert to Pharmacists - Because the Epilepsy Foundation has serious safety concerns regarding the switching of patients from one formulation of an antiepileptic drug to another, the Foundation is distributing this email alert to pharmacists throughout the country, bringing this very serious issue to their attention.